Cargando…
Screening for strongyloidiasis in Spain in the context of the SARS-CoV-2 pandemic: Results of a survey on diagnosis and treatment
INTRODUCTION: The generalization of treatment with dexamethasone or other immunosuppressants in patients with SARS-CoV-2 infection may increase the risk of occurrence of severe forms of strongyloidiasis. A nationwide survey was conducted to better understand the diagnostic and therapeutic situation...
Autores principales: | Rodríguez-Guardado, Azucena, Álvarez-Martínez, Miriam J., Flores, María Delmans, Sulleiro, Elena, Torrús-Tendero, Diego, Velasco, María, Membrillo, Francisco Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372776/ https://www.ncbi.nlm.nih.gov/pubmed/35970704 http://dx.doi.org/10.1016/j.eimce.2022.08.006 |
Ejemplares similares
-
Cribado de estrongiloidiosis en España en el contexto de la pandemia SARS-CoV-2: resultados de una encuesta sobre diagnóstico y tratamiento
por: Rodríguez-Guardado, Azucena, et al.
Publicado: (2023) -
Management of severe strongyloidiasis attended at reference centers in Spain
por: Martinez-Perez, Angela, et al.
Publicado: (2018) -
Imported strongyloidiasis: Data from 1245 cases registered in the +REDIVI Spanish Collaborative Network (2009-2017)
por: Salvador, Fernando, et al.
Publicado: (2019) -
Asymptomatic Strongyloidiasis among Latin American Migrants in Spain: A Community-Based Approach
por: Ramos-Sesma, Violeta, et al.
Publicado: (2020) -
Is Strongyloidiasis Endemic in Spain?
por: Martinez-Perez, Angela, et al.
Publicado: (2015)